Capricorn Fund Managers Ltd Takes Position in Liquidia Corporation $LQDA

Capricorn Fund Managers Ltd bought a new position in Liquidia Corporation (NASDAQ:LQDA) in the 1st quarter, HoldingsChannel reports. The fund bought 247,405 shares of the company’s stock, valued at approximately $9,337,000. Liquidia makes up 1.5% of Capricorn Fund Managers Ltd’s portfolio, making the stock its 20th biggest holding.

A number of other institutional investors and hedge funds have also modified their holdings of LQDA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Liquidia by 4.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock valued at $556,000 after acquiring an additional 1,700 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Liquidia by 10.7% in the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock worth $12,703,000 after acquiring an additional 82,955 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Liquidia by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock worth $1,796,000 after acquiring an additional 16,022 shares in the last quarter. Creative Planning raised its holdings in shares of Liquidia by 40.7% during the second quarter. Creative Planning now owns 26,840 shares of the company’s stock worth $334,000 after acquiring an additional 7,765 shares in the last quarter. Finally, Legal & General Group Plc boosted its position in Liquidia by 13.4% during the second quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock valued at $1,174,000 after purchasing an additional 11,111 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Insiders Place Their Bets

In other news, Director Stephen M. Bloch sold 318,893 shares of Liquidia stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $50.23, for a total value of $16,017,995.39. Following the transaction, the director directly owned 1,870,042 shares in the company, valued at approximately $93,932,209.66. The trade was a 14.57% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Paul B. Manning sold 200,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $63.91, for a total value of $12,782,000.00. Following the transaction, the director directly owned 716,311 shares of the company’s stock, valued at $45,779,436.01. This represents a 21.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,302,030 shares of company stock valued at $132,996,894 in the last quarter. Insiders own 25.60% of the company’s stock.

Liquidia Stock Up 6.1%

LQDA opened at $79.73 on Wednesday. The firm has a market cap of $7.09 billion, a P/E ratio of 569.54 and a beta of 0.58. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. The business has a 50 day moving average price of $58.25 and a 200 day moving average price of $44.42. Liquidia Corporation has a twelve month low of $11.85 and a twelve month high of $80.69.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The company had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. The business’s quarterly revenue was up 4187.1% on a year-over-year basis. Research analysts forecast that Liquidia Corporation will post 3.02 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on LQDA shares. Bank of America restated a “neutral” rating and issued a $79.00 target price (up from $64.00) on shares of Liquidia in a research note on Monday. BTIG Research lifted their price target on Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research note on Tuesday, April 21st. Raymond James Financial restated a “strong-buy” rating and issued a $68.00 price objective on shares of Liquidia in a report on Thursday, June 4th. Finally, Oppenheimer set a $75.00 price objective on shares of Liquidia in a research report on Friday, June 5th. Three equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $68.88.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).